1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Mental Health Screening Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Mental Health Screening Market, by Component
8.1.1. Software
8.1.1.1. Market Revenue and Forecast
8.1.2. Hardware
8.1.2.1. Market Revenue and Forecast
9.1. Mental Health Screening Market, by Solution Type/Platform
9.1.1. Online Platforms
9.1.1.1. Market Revenue and Forecast
9.1.2. Telehealth & Virtual Care
9.1.2.1. Market Revenue and Forecast
9.1.3. mHealth Apps
9.1.3.1. Market Revenue and Forecast
10.1. Mental Health Screening Market, by Screening Method/Assessment
10.1.1. Self-Reported Questionnaires & Surveys
10.1.1.1. Market Revenue and Forecast
10.1.2. Clinical Interviews
10.1.2.1. Market Revenue and Forecast
10.1.3. Biomarker/Observation/Other Tools
10.1.3.1. Market Revenue and Forecast
11.1. Mental Health Screening Market, by Application
11.1.1. Physiological/Psychological Disorders
11.1.1.1. Market Revenue and Forecast
11.1.2. Cognitive Disorders
11.1.2.1. Market Revenue and Forecast
11.1.3. Behavioral Disorders/Others
11.1.3.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Component
12.1.2. Market Revenue and Forecast, by Solution Type/Platform
12.1.3. Market Revenue and Forecast, by Screening Method/Assessment
12.1.4. Market Revenue and Forecast, by Application
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Component
12.1.5.2. Market Revenue and Forecast, by Solution Type/Platform
12.1.5.3. Market Revenue and Forecast, by Screening Method/Assessment
12.1.5.4. Market Revenue and Forecast, by Application
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Component
12.1.6.2. Market Revenue and Forecast, by Solution Type/Platform
12.1.6.3. Market Revenue and Forecast, by Screening Method/Assessment
12.1.6.4. Market Revenue and Forecast, by Application
12.2. Europe
12.2.1. Market Revenue and Forecast, by Component
12.2.2. Market Revenue and Forecast, by Solution Type/Platform
12.2.3. Market Revenue and Forecast, by Screening Method/Assessment
12.2.4. Market Revenue and Forecast, by Application
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Component
12.2.5.2. Market Revenue and Forecast, by Solution Type/Platform
12.2.5.3. Market Revenue and Forecast, by Screening Method/Assessment
12.2.5.4. Market Revenue and Forecast, by Application
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Component
12.2.6.2. Market Revenue and Forecast, by Solution Type/Platform
12.2.6.3. Market Revenue and Forecast, by Screening Method/Assessment
12.2.6.4. Market Revenue and Forecast, by Application
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Component
12.2.7.2. Market Revenue and Forecast, by Solution Type/Platform
12.2.7.3. Market Revenue and Forecast, by Screening Method/Assessment
12.2.7.4. Market Revenue and Forecast, by Application
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Component
12.2.8.2. Market Revenue and Forecast, by Solution Type/Platform
12.2.8.3. Market Revenue and Forecast, by Screening Method/Assessment
12.2.8.4. Market Revenue and Forecast, by Application
12.3. APAC
12.3.1. Market Revenue and Forecast, by Component
12.3.2. Market Revenue and Forecast, by Solution Type/Platform
12.3.3. Market Revenue and Forecast, by Screening Method/Assessment
12.3.4. Market Revenue and Forecast, by Application
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Component
12.3.5.2. Market Revenue and Forecast, by Solution Type/Platform
12.3.5.3. Market Revenue and Forecast, by Screening Method/Assessment
12.3.5.4. Market Revenue and Forecast, by Application
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Component
12.3.6.2. Market Revenue and Forecast, by Solution Type/Platform
12.3.6.3. Market Revenue and Forecast, by Screening Method/Assessment
12.3.6.4. Market Revenue and Forecast, by Application
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Component
12.3.7.2. Market Revenue and Forecast, by Solution Type/Platform
12.3.7.3. Market Revenue and Forecast, by Screening Method/Assessment
12.3.7.4. Market Revenue and Forecast, by Application
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Component
12.3.8.2. Market Revenue and Forecast, by Solution Type/Platform
12.3.8.3. Market Revenue and Forecast, by Screening Method/Assessment
12.3.8.4. Market Revenue and Forecast, by Application
12.4. MEA
12.4.1. Market Revenue and Forecast, by Component
12.4.2. Market Revenue and Forecast, by Solution Type/Platform
12.4.3. Market Revenue and Forecast, by Screening Method/Assessment
12.4.4. Market Revenue and Forecast, by Application
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Component
12.4.5.2. Market Revenue and Forecast, by Solution Type/Platform
12.4.5.3. Market Revenue and Forecast, by Screening Method/Assessment
12.4.5.4. Market Revenue and Forecast, by Application
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Component
12.4.6.2. Market Revenue and Forecast, by Solution Type/Platform
12.4.6.3. Market Revenue and Forecast, by Screening Method/Assessment
12.4.6.4. Market Revenue and Forecast, by Application
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Component
12.4.7.2. Market Revenue and Forecast, by Solution Type/Platform
12.4.7.3. Market Revenue and Forecast, by Screening Method/Assessment
12.4.7.4. Market Revenue and Forecast, by Application
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Component
12.4.8.2. Market Revenue and Forecast, by Solution Type/Platform
12.4.8.3. Market Revenue and Forecast, by Screening Method/Assessment
12.4.8.4. Market Revenue and Forecast, by Application
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Component
12.5.2. Market Revenue and Forecast, by Solution Type/Platform
12.5.3. Market Revenue and Forecast, by Screening Method/Assessment
12.5.4. Market Revenue and Forecast, by Application
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Component
12.5.5.2. Market Revenue and Forecast, by Solution Type/Platform
12.5.5.3. Market Revenue and Forecast, by Screening Method/Assessment
12.5.5.4. Market Revenue and Forecast, by Application
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Component
12.5.6.2. Market Revenue and Forecast, by Solution Type/Platform
12.5.6.3. Market Revenue and Forecast, by Screening Method/Assessment
12.5.6.4. Market Revenue and Forecast, by Application
13.1. Adaptive Testing Technologies (U.S.)
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Proem Behavioural Health (U.S.)
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Aiberry (U.S.)
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. SonderMind Inc. (U.S.)
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Riverside Community Care (U.S.)
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Clarigent Health (U.S.)
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Kintsugi Mindful Wellness, Inc. (U.S.)
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Thymia Limited (UK)
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Ellipsis Health Inc. (U.S.)
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Headspace Health (U.S.)
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
